MedPath

A clinical trail to evaluate the effect of Satvavajaya Chikitsa with Shankhapushpi capsule in Body Dysmorphic Disorder

Phase 2
Not yet recruiting
Conditions
Other somatoform disorders. Ayurveda Condition: MANOVAHASROTOVIKARAH,
Registration Number
CTRI/2025/05/087398
Brief Summary

This is a randomised open label parallel group study comparing the safety and efficacy of the trial drug Group A- Shankhapushpi Capsule (500 mg) 2 TID, Before Food with warm water and Group B– Shannkhapushpi Capsule (500 mg) 2 tid, Before Food with warm water and Satvavajaya Chikitsa once daily  for a period of 14 days. The study will be conducted in Shri Dharmasthala Manjunatheshwara College of Ayurveda, Kuthpady, Udupi. The primary measures will be assessed throughAppearance anxiety Inventory for body dysmorphic disorder by Cambridge University of press and assessment , Manasika Bhava scale. Hence, the study is an effort to prove the efficacy and compare the effect of Shankhapushpi capsules and Shankhapushpi capsule along with Satvavajaya Chikitsa in Body Dysmorphic Disorder.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

1)Individuals fulfilling diagnostic criteria of Body Dysmorphic Disorder as per DSM-5 2)Achintana, Atichintana 3)Patients are selected of age group between 18-40 years 4)Patients willing to sign informed consent.

Exclusion Criteria

1)Patients suffering from any systemic illness, psychiatric illness or any other metabolic disorders interfering with the treatment protocol 2)Pregnant and lactating women 3)Patient suffering from substance abuse.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
2) Ham- A scaleParameters will be scored by standard method and will be assessed before and after treatment on 0th and 14th day (at 2 weeks)
3) WHO Quality of life scaleParameters will be scored by standard method and will be assessed before and after treatment on 0th and 14th day (at 2 weeks)
Mann-Whitney U test in between the groups.Parameters will be scored by standard method and will be assessed before and after treatment on 0th and 14th day (at 2 weeks)
4) Manobhava scaleParameters will be scored by standard method and will be assessed before and after treatment on 0th and 14th day (at 2 weeks)
All the subjectiveParameters will be scored by standard method and will be assessed before and after treatment on 0th and 14th day (at 2 weeks)
parameters and scales will be assessed statistically using Wilcoxon signed rank test within the groups andParameters will be scored by standard method and will be assessed before and after treatment on 0th and 14th day (at 2 weeks)
Parameters will be assessed on Day 0 and Day 14 using standard toolsParameters will be scored by standard method and will be assessed before and after treatment on 0th and 14th day (at 2 weeks)
1) Appearance Anxiety Inventory for BDD(Cambridge university)Parameters will be scored by standard method and will be assessed before and after treatment on 0th and 14th day (at 2 weeks)
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

SDM COLLEGE OF AYURVEDA,HOPSITAL AND RESEARCH CENTRE

🇮🇳

Udupi, KARNATAKA, India

Shri Dharmasthala Manjunatheshwara College of Ayurveda, Hospital and Research Centre, Kuthpady

🇮🇳

Udupi, KARNATAKA, India

SDM COLLEGE OF AYURVEDA,HOPSITAL AND RESEARCH CENTRE
🇮🇳Udupi, KARNATAKA, India
DR PRIYADARSHINI
Principal investigator
7899216053
priyapriyadarshini455@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.